GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Jul 15, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jul 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, transaction-in-own-shares
TL;DR
GSK is buying back its own stock via Merrill Lynch.
AI Summary
GSK plc announced on July 15, 2025, that it has purchased its own shares through its corporate stockbroker, Merrill Lynch International. The filing does not specify the number of shares purchased or the total dollar amount involved in these transactions.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This filing is a routine report of share transactions and does not contain new material financial or operational information.
Key Players & Entities
- GSK plc (company) — Registrant
- Merrill Lynch International (company) — Corporate stockbroker
- July 2025 (date) — Reporting period
- 20250715 (date) — Filing date
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K filing reports on GSK plc's transactions in its own shares during the month of July 2025.
Who is acting as GSK's stockbroker for these transactions?
Merrill Lynch International is acting as GSK's corporate stockbroker for these share purchases.
When was this filing submitted to the SEC?
This filing was submitted to the SEC on July 15, 2025.
Does GSK file annual reports under Form 20-F or 40-F?
GSK indicates it files annual reports under cover of Form 20-F.
What was GSK's former name?
GSK plc was formerly known as GlaxoSmithKline plc, with a name change occurring on January 5, 2001.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 15, 2025 regarding GSK plc (GLAXF).